HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.

6th Edition of Euro-Global Conference on Biotechnology and Bioengineering

September 28-30 | Hybrid Event

September 28-30, 2026 | London, UK

Biosafety

Biosafety

For research or instructional purposes, biosafety laboratories are carefully built facilities where infectious or potentially infectious pathogens are handled and/or contained. The goal of a biosafety laboratory is to keep personnel and the rest of the environment safe from biohazards. Biohazard control is divided into four stages, referred to as biosafety levels 1 through 4. Biosafety refers to the avoidance of large-scale biological integrity loss, with an emphasis on both ecological and human health. Regular biosafety assessments in laboratory settings, as well as tight protocols to follow, are among the preventative methods. Biosafety is a term used to describe the process of safeguarding against potentially dangerous events. A continuous risk management assessment and enforcement procedure for biosafety is used by many laboratories that handle biohazards. Biosafety is becoming a global concern that necessitates multilevel resources and international collaboration to monitor, prevent, and correct unintended and malicious release of biologics samples, as well as to prevent bioterrorists from obtaining biologics samples to create biologic weapons of mass destruction.

Committee Members
Speaker at Biotechnology and Bioengineering 2026 - Murray Moo Young

Murray Moo Young

University of Waterloo, Canada
Speaker at Biotechnology and Bioengineering 2026 - Limongi Tania

Limongi Tania

University of Turin, Italy
Speaker at Biotechnology and Bioengineering 2026 - Luis Jesus Villarreal Gomez

Luis Jesus Villarreal Gomez

Universidad Autonoma de Baja California, Mexico

Submit your abstract Today

Watsapp